# HotKnot Therapeutics, Inc. — Form D

HotKnot Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-23. The offering totals $72.0M. Industry: Biotechnology.

## Offering

- Filed: 2021-02-23
- Form: D
- Accession: 0001847369-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $72.0M
- Remaining: $72.0M
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390254

## Issuer

- Name: HotKnot Therapeutics, Inc.
- CIK: 0001847369
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 450 KENDALL STREET, CAMBRIDGE, MA, 02142
- Phone: 617-425-9200

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Todd Foley | Director | South San Francisco, CA |
| Matthew Roden | Director | Boston, MA |
| Lloyd M Segal | Director | Cambridge, MA |
| Brian Goodman | Executive Officer | Redwood City, CA |
| Matthew Roden | Executive Officer | Boston, MA |

## More

- [CIK 1847369 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1847369&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001847369-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.